In the case of AATD, past efforts focused on developing small molecules or peptides that block the aggregation of AAT-Z by interfering with the loop-sheet insertion mechanism responsible for NE inhibitory activity40,80–84. The gene discussed is PSMB7; the disease is alpha 1-antitrypsin deficiency.